T-Cell Transfer Therapy Targeting Mutant KRAS
- PMID: 28199803
- PMCID: PMC6697099
T-Cell Transfer Therapy Targeting Mutant KRAS
Conflict of interest statement
No potential conflict of interest relevant to this letter was reported.
Comment on
-
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.N Engl J Med. 2016 Dec 8;375(23):2255-2262. doi: 10.1056/NEJMoa1609279. N Engl J Med. 2016. PMID: 27959684 Free PMC article.
-
T-Cell Transfer Therapy Targeting Mutant KRAS.N Engl J Med. 2017 Feb 16;376(7):e11. doi: 10.1056/NEJMc1616637. N Engl J Med. 2017. PMID: 28207208 No abstract available.
-
T-Cell Transfer Therapy Targeting Mutant KRAS.N Engl J Med. 2017 Feb 16;376(7):e11. doi: 10.1056/NEJMc1616637. N Engl J Med. 2017. PMID: 28207209 Free PMC article. No abstract available.
References
-
- Balli D, Rech AJ, Stanger BZ, Vonderheide RH. Immune cytolytic activity stratifies molecular subsets of human pancreatic cancer. Clin Cancer Res 2016. December 22 (Epub ahead of print). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous